Lansforsakringar Fondforvaltning’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$88.7M Buy
3,158,825
+103,600
+3% +$2.76M 0.46% 36
2025
Q4
$76.1M Buy
3,055,225
+162,117
+6% +$4.09M 0.38% 44
2025
Q3
$73.7M Sell
2,893,108
-426,228
-13% -$10.5M 0.38% 41
2025
Q2
$80.5M Sell
3,319,336
-111,097
-3% -$2.59M 0.46% 37
2025
Q1
$86.9M Sell
3,430,433
-66,558
-2% -$1.74M 0.53% 30
2024
Q4
$92.8M Buy
+3,496,991
New +$94.9M 0.52% 30

Other funds holding PFE

Lansforsakringar Fondforvaltning's PFE Position: Q1 2026 in Review

Lansforsakringar Fondforvaltning increased its Pfizer (PFE) stake by 3.4% in Q1 2026, buying an estimated $2.76M and bringing the position to 3,158,825 shares worth $88.7M. The position accounts for 0.46% of the portfolio, ranked #36.

Lansforsakringar Fondforvaltning first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. The position peaked at $92.8M in Q4 2024. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Lansforsakringar Fondforvaltning held 3,158,825 shares of Pfizer worth $88.7M as of Q1 2026.
  • Lansforsakringar Fondforvaltning bought 103,600 Pfizer shares in Q1 2026, an estimated $2.76M.
  • Pfizer made up 0.46% of Lansforsakringar Fondforvaltning's portfolio in Q1 2026, its #36 holding.
  • Lansforsakringar Fondforvaltning first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • Lansforsakringar Fondforvaltning's Pfizer position peaked at $92.8M in Q4 2024.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q1 2026, filed 23 Apr 2026.